References
- Writing Group for the Women's Health Initia-tive Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal wo-men: principal results from the Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2002;288:321–33
- Palacios S, Calaf J, Cano A, Parrilla JJ; Spanish Menopause Society (AEEM). Relevant results of the WHI study for the management of the menopause in Spain. Maturitas 2003;44:83–6
- Lemay A. The relevance of the Women's Health Initiative results on combined hormone replace-ment therapy in clinical practice. J Obstet Gynaecol Can 2002;24:711–15
- Speroff L. HT. A clinician demurs. Fertil Steril 2003;80(Suppl 4):15–18
- McDonough PG. The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study. Fertil Steril 2002;78:951–6
- Vickers M, Meade T, Darbyshire J. WISDOM: history and early demise — was it inevitable? Climacteric 2002;5:317–25
- Machens K, Schmidt-Gollwitzer K. Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epide-miological dilemma? Hum Reprod 2003;18:1992–9
- Burger H. Hormone replacement therapy in the post-Women's Health Initiative era. Report on a meeting held in Funchal, Madeira, February 24–25,2003. Climacteric 2003;6\(Suppl 1):11–36
- Vinker S, Kaplan B, Yaphe J, et al. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel. Climacteric 2003;6:75–80
- Taechakraichana N, Wilawan K, Wipatavit V, et al. Hormone replacement therapy: attitude and acceptance of Bangkokian women. J Med Assoc Thai 2003;86(Suppl 2):5385–98
- Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942–4
- Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Sulkes J, Phisher M. Gynecologists' trends and attitudes toward prescribing hor-mone replacement therapy during menopause. Menopause 2002;9:354–9
- Elinson L, Cohen MM, Elmslie T. Hormone replacement therapy: a survey of Ontario phy-sicians' prescribing practices. Can Med Assoc J 1999;161:695–8
- Kaplan B, Rabinerson D, Yogev Y, Bar-Hava I, Bar J, Orvieto R. A survey of physicians' attitude and approach to hormone replacement therapy during menopause. Clin Exp Obstet Gynecol 2002;29:31–3
- Levy BT, Ritchie JM, Smith E, Gray T, Zhang W. Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol 2003;101:114–22
- Blumel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone replacement therapy on postmenopausal women's health perceptions. Menopause 2003;10:235–40
- Scheid DC, Coleman MT, Hamm RM. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmeno-pausal women? J Am Board Fam Pract 2003;16:270–7
- Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996;23:47–53
- The Women's Health Initiative Steering Com-mittee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. J Am Med Assoc 2004;291:1701–12